Skip to main content
HR 5745 117th Congress House Health Administrative law and regulatory procedures Aging Cardiovascular and respiratory health Cell biology and embryology Child health Department of Health and Human Services Emergency medical services and trauma care Immunology and vaccination Infectious and parasitic diseases Medical research Medical tests and diagnostic methods Medicare Research administration and funding

COVID–19 Access to Testing and Support for Immune Response Research Act of 2021

Introduced: October 27, 2021 Introduced by: Dunn, Neal P. Republican · Florida See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 28, 2021
Referred to the Subcommittee on Health.
Oct 27, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 27, 2021
Introduced in House
Oct 27, 2021
Referred to the Subcommittee on Health.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

COVID-19 Access to Testing and Support for Immune Response Research Act of 2021

This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.

What's happening now October 28, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5745: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5745/
MLA
"H.R. 5745: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5745/.
Bluebook (legal)
H.R. 5745, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5745/.
Markdown link
[H.R. 5745: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021](https://openamerica.io/bill/117-HR-5745/)
Report a problem